Improvement of intractable acne in a man following testosterone suppression using danazol
Abstract
Sometimes, oral contraceptives have been successful in treating resistant cases of acne in girls, probably by reducing testosterone levels (both total and free) by suppressing the pituitary gonadotropins. Danazol is a new agent which also suppresses gonadotropins, but it is an impeded androgen with negligible estrogen effects. It would seem, therefore, a more appropriate drug to treat intractable acne in men since it suppresses testosterone levels. Presented herein is a twenty-five year old man with severe acne that did not improve after treatment with conventional topical agents and systemic antibiotics. The patient's condition showed considerable improvement after three months of danazol therapy. However, although, the acne remained suppressed while the patient was receiving the medication, when the medication was stopped, the acne returned. Again, the condition was suppressed after the medication was resumed. Other than mild weight gain, no significant side effects were noted in this patient. His libido remained unchanged and no problems with impotence developed. Danazol may prove to be a useful drug for treating acne especially in postpubertal men in whom the condition does not respond with conventional therapy.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.